Abstract
No public abstract is available from the verified source records.
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Introducing JACC: Basic to Translational Science: why now?
2016
Neuromodulation of the failing heart: lost in translation?
2016
Broadview Ventures: investing in the future of cardiovascular therapy
2016
Drugs, devices, and the FDA: Part 1: an overview of approval processes for drugs
2016
Detection and management of geographic disparities in the TOPCAT trial: lessons learned and derivative recommendations
2016
Spironolactone for heart failure with preserved ejection fraction
10.1056/nejmoa1313731 · 2014
No additional external references are available.